← Leaderboards
Gary Horwith
Sequella, Inc.
$261,175
Attributed
$261,175
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$261,175 · 1
By mechanism
R34$261,175 · 1
Top collaborators
No co-investigators on record.
Most similar at Sequella, Inc.
Same institution · by research overlap
- Leo Einck$3,287,911
- Marina N Protopopova$5,540,511
- Matthew Charles Mulvey$684,296
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultAfricanAntibioticsAntitubercular AgentsApplications GrantsCessation Of LifeClinical ResearchClinical Trial Protocol DocumentClinical TrialsClinical Trials DesignCommunicable DiseasesConsent FormsData ManagementDesignDisease ResistanceDoseDrug CandidateDrug CombinationsDrug ResistanceDrug Resistance In TuberculosisDrug Resistant TuberculosisDrug-SensitiveEastern EuropeAdherence (Attribute)